Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
FDA Approves First KRAS Inhibitor: Sotorasib
HTML
Details
Locations
Year:
2021
Type:
article
Source:
Cancer Discovery
DOI:
10.1158/2159-8290.cd-nb2021-0362
Language:
English
Topic:
Lung Cancer Treatments and Mutations
Subfield:
Pulmonary and Respiratory Medicine
Field:
Medicine
Domain:
Health Sciences
Keywords:
sotorasib,
KRAS G12C mutation,
KRAS inhibitors,
non-small cell lung cancer,
FDA drug approval,
targeted therapy,
progression-free survival,
platinum-based chemotherapy,
PD-1/PD-L1 inhibitors
show all 9
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W4206804220
FWCI:
6.223
Cites:
Cited by:
62
Related to:
10